期刊目次

加入编委

期刊订阅

添加您的邮件地址以接收即将发行期刊数据:

Open Access Article

International Research in Chinese Medicine. 2022; 2: (3) ; 30-33 ; DOI: 10.12208/j.ircm.20220054.

The value of Jiawei Danggui Buxue Decoction in the treatment of chronic heart failure with anemia
加味当归补血汤治疗慢性心衰伴贫血的价值

作者: 徐天一 *

桐乡市梧桐街道社区卫生服务中心 浙江桐乡

*通讯作者: 徐天一,单位:桐乡市梧桐街道社区卫生服务中心 浙江桐乡;

发布时间: 2022-10-08 总浏览量: 419

摘要

目的 分析研究慢性心衰伴贫血患者采取加味当归补血汤治疗的效果。方法 运用随机数字表法将本院在2020年4月-2021年4月期间收治的82慢性心衰伴贫血患者进行分组。其中一组为参考组(n=41),本组接受常规西药治疗。另一组为实验组(n=41),本组在常规西药治疗的基础上实行加味当归补血汤治疗。以治疗有效率、中医证候积分、Hb、血浆NT-proBNP、6MWT评价两组治疗效果。结果 实验组治疗有效率明显要比参考组高(P<0.05)。两组治疗前中医证候积分对比差异较小,无法满足统计学含义(P>0.05)。经治疗后,实验组中医证候积分明显要比参考组低(P<0.05)。实验组Hb、6MWT指标要比参考组高(P<0.05),血浆NT-proBNP要比参考组较低(P<0.05)。结论 在慢性心衰伴贫血患者治疗中采取加味当归补血汤治疗效果确切,可促进患者的治疗效果,改善其相关症状及指标,进而促进患者康复,此种治疗方法值得在临床上推广应用。

关键词: 加味当归补血汤;慢性心衰;贫血;治疗有效率;中医证候积分;Hb;血浆NT-proBNP;6MWT

Abstract

Objective To analyze and study the effect of modified Danggui Buxue decoction in patients with chronic heart failure and anemia.
Methods Using the random number table method, 82 patients with chronic heart failure and anemia who were admitted to our hospital from April 2020 to April 2021 were divided into groups. One group was the reference group (n=41), and this group received conventional western medicine treatment. The other group was the experimental group (n=41). This group was treated with modified Danggui Buxue decoction on the basis of conventional western medicine treatment. The therapeutic effects of the two groups were evaluated by the treatment efficiency, TCM syndrome score, Hb, plasma NT-proBNP and 6MWT.
Results The effective rate of treatment in the experimental group was significantly higher than that in the reference group (P<0.05). Before treatment, there was little difference in TCM syndrome scores between the two groups, which could not meet the statistical significance (P>0.05). After treatment, the TCM syndrome scores in the experimental group were significantly lower than those in the reference group (P<0.05). The Hb and 6MWT indexes of the experimental group were higher than those of the reference group (P<0.05), and the plasma NT-proBNP was lower than that of the reference group (P<0.05).
Conclusion   In the treatment of patients with chronic heart failure and anemia, the treatment effect of Jiawei Danggui Buxue Decoction is definite, which can promote the treatment effect of patients, improve their related symptoms and indicators, and then promote the recovery of patients. This treatment method is worthy of clinical application.

Key words: Jiwei Danggui Buxue Decoction; chronic heart failure; anemia; treatment efficiency; TCM syndrome score; Hb; plasma NT-proBNP; 6MWT

参考文献 References

[1] 张杼惠,刘建和,曹蛟.王行宽基于“形精气味”理论治疗慢性心力衰竭伴贫血经验[J].中国中医药信息杂志,2021,28(11):130-133.

[2] 姜涛,陈亚南.加味当归补血汤联合西药治疗慢性心力衰竭伴贫血的疗效分析[J].实用中医内科杂志,2022,36(03):119-121.

[3] 叶悦.加味当归补血汤治疗慢性心衰伴贫血患者的效果分析[J].实用中西医结合临床,2021,21(06):13-14.

[4] 温馨,黄炜,韩晓东.加味当归补血汤治疗慢性心衰伴贫血患者的疗效观察[J].中西医结合心血管病电子杂志,2020,8(31):160-162.

[5] 李金泽.加味当归补血汤治疗慢性心衰伴贫血的临床疗效及对心功能的影响分析[J].中西医结合心血管病电子杂志,2020,8(31):174-178.

[6] 陈志.自拟加味当归补血汤治疗下肢骨折术后贫血[J].中国卫生标准管理,2020,11(03):105-107.

[7] 黄美艳,蔡秀江.当归补血汤临床应用研究进展[J].实用中医药杂志,2019,35(11):1415-1417.

[8] 田红艳.加味当归补血汤治疗慢性心衰伴贫血疗效观察[J].首都食品与医药,2019,26(19):193-194.


引用本文

徐天一, 加味当归补血汤治疗慢性心衰伴贫血的价值[J]. 国际中医药研究, 2022; 2: (3) : 30-33.